Point72 »

Perspective Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-06-30 $118k 12k 9.97

More positions owned by Point72

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Pfizer (PFE)
Adobe Systems Incorporated Call Option (ADBE)
Amgen Call Option (AMGN)
salesforce Call Option (CRM)
Bristol Myers Squibb (BMY)
Amazon (AMZN)
Raytheon Technologies Corp (RTX)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Visa Com Cl A (V)
Spotify Technology S A SHS (SPOT)
Eli Lilly & Co. Call Option (LLY)

View all positions for Point72

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics